Age at onset of breast cancer and variants of IL23R gene.

<p>Age at onset of breast cancer and variants of IL23R gene.</p

Frequencies of genotypes and alleles of two IL23R SNPs in breast cancer patients and controls.

a<p><i>P</i> = 0.0365 after correcting the <i>P</i>-value for multiple testing with the Haploview program using 10,000 permutations.</p

Clinical features associated with rs1884444 in IL23R gene.

<p>Abbreviations: TZ, tumor size; Her-2, human epidermal growth factor receptor-2.</p

Haplotype frequencies in breast cancer patients and healthy controls.

<p>The haplotypes shown occurred with a frequency of ≥10% in the case-control population.</p>a<p><i>P</i> = 0.0179 and</p>b<p><i>P</i> = 0.0259 after correcting the <i>P</i>-value for multiple testing with the Haploview program using 10,000 permutations.</p

Clinical features associated with IL-17A and IL-17F gene polymorphisms.

<p>Clinical features associated with IL-17A and IL-17F gene polymorphisms.</p

Haplotype frequencies in breast cancer patients and healthy controls.

<p>The haplotypes contain the following SNPs in the order listed: IL-17A: rs2275913, rs3819025 and rs3748067; IL-17F: rs763780, rs7771511, rs12203582, rs9382084 and rs1266828. The haplotypes occurred with a frequency of = 10% in the case-control population.</p>a<p><i>P</i> = 0.0471 after correcting the <i>P</i>-value for multiple testing with the Haploview program using 10,000 permutations.</p

Allele frequencies of eight SNPs in the IL-17A and IL-17F genes.

†<p>controls = 501, missing = 1;</p>‡<p>controls = 499, missing = 3.</p>a<p><i>P</i> = 0.0311 after correcting the <i>P</i>-value for multiple testing with the Haploview program using 10,000 permutations.</p